TriVita Health -- Research and Focus

TriVita Health -- Research and Focus

Popular Drug Fosamax May Lead To Atrial Fibrillation

Seattle, Washington
A study led by Dr. Susan Heckbert of the University of Washington and Group Health, observed 719 women with confirmed atrial fibrillation (irregular heart rhythm) under “real world” situations, versus a control group of 966 healthy women.  The research set out to see if there was a connection between the use of Fosamax (a popular drug used to treat osteoporosis) and the development of atrial fibrillation.  The study discovered that 6.5% of women with atrial fibrillation had used Fosamax, compared to 4.1% of the control group.


Research Shows Link Between Alcohol Intake and Breast Cancer in Women

Atlanta, Georgia
Data on the drinking habits of 70,033 women of diverse backgrounds was analyzed by researchers at Kaiser Permanente.  Researchers were trying to discover whether the type or amount of alcohol consumed impacted a woman’s risk of developing breast cancer.  Lead examiner, Dr. Yan Li, states that “it makes no difference if a woman drinks wine, beer or liquor – it’s the quantity consumed” that is critical.  While Li cannot confirm why alcohol seems to raise a woman’s risk for developing breast cancer, she points to evidence which indicates that alcohol could change the pathway of female hormones and create hormone-sensitive breast cancer.

Women Who Take Folic Acid May Reduce Their Risk of Developing Hypertension

New York, New York
A report published in The Journal of the American Medical Association indicates that all women should consider taking a folic acid supplements as early as the reproductive age (age will vary with different ethnic societies).  This supplementation is important for both the baby’s health and women’s overall well-being.  This study followed two groups of women over eight years.  The first group (women ranging from 25 to 42 years of age) who consumed 1,000 micrograms of folic acid a day, were discovered to have decreased their risk of developing hypertension by 46%.  The second group (women ranging from 30 to 55 years of age), who took the same amount of folic acid, decreased their risk of developing hypertension by 18%.  The study later gave the women in both groups only 400 micrograms.  The women in the younger group still decreased their risk of developing hypertension by 40%; the women in the older group – by 13%.  This study suggests that the higher the amount of folic acid supplementation, the better the chance of preventing the development of hypertension.

Posted by:
Terry L. Allison, Sr.
TriVita
Independent Business Affiliate
13134349
Skype: allisonmarketinggroup

http://trivitaproduct.info/
http://trivitasuccessbusiness.blogspot.com/
http://www.trivitaproduct.info/trivita.html